The Fed is behind its usual schedule for easing policy due to data delays and COVID-era distortions. This has suppressed the typical market rotation but means the eventual dovish policy will likely be stronger than expected, creating significant upside for early-cycle investments.
Related Insights
The Federal Reserve is easing monetary policy at a time when corporate earnings are already growing strongly. This rare combination has only occurred once in the last 40 years, in 1998, which was followed by two more years of a powerful bull market run.
The Bureau of Labor Statistics' decision to delay key employment reports until after the December FOMC meeting has dramatically reduced the probability of a rate cut. This 'data vacuum' forces the Fed to be cautious and lean hawkish, as making a dovish pivot without supporting data is too risky.
Small and mid-cap biotech companies are primarily "capital consumers," making them highly sensitive to interest rates. As the Fed moves toward rate cuts, cheaper capital is expected to unlock significant spending on R&D pipelines and M&A activity, historically making biotech a top-performing sector after the first cut.
Despite conflicting inflation data, the Federal Reserve feels compelled to cut interest rates. With markets pricing in a 96% probability of a cut, failing to do so would trigger a significant stock market shock. This makes managing market expectations a primary driver of the policy decision, potentially overriding pure economic rationale.
With the Federal Reserve signaling a market backstop, capital is flowing from concentrated large-cap tech winners into more cyclical, under-loved small-cap stocks (IWM). This support de-risks 'Main Street' sectors and signals a potential broadening of the market rally.
A high-conviction view for 2026 is a material steepening of the U.S. Treasury yield curve. This shift will not be driven by long-term rates, but by the two-year yield falling as markets more accurately price in future Federal Reserve rate cuts.
Current rate cuts, intended as risk management, are not a one-way street. By stimulating the economy, they raise the probability that the Fed will need to reverse course and hike rates later to manage potential outperformance, creating a "two-sided" risk distribution for investors.
In shallow easing cycles, historical data shows Treasury yields don't bottom on the day of the final rate cut. Instead, they typically hit their low point one to two months prior, signaling a rebound even as the Fed completes its easing actions.
A key argument for market bulls is that the Federal Reserve is cutting interest rates while a potential AI bubble is inflating. This is a stark contrast to the dot-com era, when the Fed hiked by 175 basis points, making historical analogies difficult and creating a unique tailwind for equities.
Jerome Powell's "driving in fog" analogy highlights the Fed's strategy of using uncertainty, such as a government shutdown delaying economic data, to justify slowing down policy changes like rate cuts. This gives them flexibility to guide markets later through speeches without being locked into a specific path.
